India's Sai Life Sciences gains on higher quarterly profit, MSCI inclusion

Sai Life Sciences

14/05/2025 09:06

** India's Sai Life Sciences SAIE.NS climbs 5.2% to 763.10 rupees, set for third straight session of gains

** Contract drugmaker reports a 57% climb in its fourth-quarter consol profit on strong demand for its active pharmaceutical ingredients

** APIs are the main components in a drug which produce the desired health effects

** MSCI also added SAIE to its India small-cap index in its May rejig

** Inclusion to result in inflows worth $7 million, JM Financial analysts say

** Stock down 0.2% since listing in December 2024

(Reporting by Kashish Tandon in Bengaluru)

((Kashish.tandon@thomsonreuters.com))